WW lauches WeightWatchers GLP-1 Program

WeightWatchers announced the launch of WeightWatchers GLP-1 Program to provide tailored behavioral support for individuals on a GLP-1 medication. The new program was scientifically designed to help support the unique behavioral and nutritional needs one faces while on a GLP-1 journey. WeightWatchers continues to offer program solutions based on scientific evidence and consumer research. The medical community recognizes obesity as a chronic condition, and the need to treat it as such; so does the company’s approach to new treatment offerings. The new WeightWatchers GLP-1 Program, which was developed by WeightWatchers’ team of obesity specialists, clinicians, behavior-change scientists, dietitians and fitness experts, solves a gap in the market as members navigate life on new weight loss medications. The program supports members with building and sustaining healthy habits while appetite is significantly reduced, such as ensuring adequate nutrition – specifically protein and nutrient dense foods, as well as hydration. It also provides movement goals and a community of people on a similar journey for support and practical tips.